NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe
Already have an account? Sign in.

ARS Pharmaceuticals Neffy Nasal Spray Approved in Japan

Japan approved neffy (epinephrine nasal spray). This needle-free option treats severe allergies (anaphylaxis) in adults and kids (>15 kg). It's the first in Japan, offering a compact, injection-free alternative. Availability starts late 2025.

09/19/2025 · 10:17 AM
SPRY
/ Don’t stop at just one post.

Related↓

Aquestive Therapeutics Faces FDA Setback for Anaphylm Drug Approval
01/09/2026 · 9:03 AM

Aquestive Therapeutics Faces FDA Setback for Anaphylm Drug Approval

Aquestive Therapeutics stock plunges after FDA identifies deficiencies in Anaphylm application, a sublingual film treatment for severe allergic reactions.

/ Subscriber only
/ Read more

Feed↓

Microsoft’s Quiet Breakup with OpenAI: The AI Acquisition Spree Begins
Featured/ 05/13/2026 · 5:15 PM

Microsoft’s Quiet Breakup with OpenAI: The AI Acquisition Spree Begins

Microsoft is buying AI startups to reduce reliance on OpenAI and build its own powerful AI systems for the future.

/ Subscriber only
Cisco Beats Q3 Estimates and Boosts 2026 Guidance
Featured/ 05/13/2026 · 4:33 PM

Cisco Beats Q3 Estimates and Boosts 2026 Guidance

Cisco beat expectations, raised its outlook, and saw strong AI demand, while announcing a restructuring plan and job cuts.

/ Subscriber only
Activist Investor Galloway Capital Takes 8.42% Stake in WW International
05/13/2026 · 1:55 PM

Activist Investor Galloway Capital Takes 8.42% Stake in WW International

WW International rose after Galloway Capital built 8.42% stake, saying company is undervalued despite debt issues.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe